New NASDAQ Psychedelic Stock is an IP Giant | Atai Life Sciences
Atai Life Sciences (NASDAQ:ATAI) is a mental health biotech company developing novel drugs (psychedelic and non-psychedelic) to cure various mental health diseases such as addiction, depression, anxiety, and PTSD. Atai recently raised $225 million in an upsized Nasdaq IPO. This impressive public offering values the company north of $2 billion.
Why the excitement for another recent biotech IPO?
It is the broad diversity of Atai’s portfolio and business offering. Atai has every single psychedelic drug that has medical and commercial viability on its platform. The familiar magic mushroom drugs, as well as a host of other psychedelic connoisseurs may not have heard of. Currently, Atai has ten programs running using Psilocybin, Arketamine, Ibogaine & Norigaine, Deu-Etifoxine, N-acetylcysteine, N, N-dimethyltryptamine, MDMA derivative, Deu-Mitragynine.
Founder Christian Angermayer sees Ibogaine as one of the more exciting drugs. He believes it is one of the only drugs that has the potential to cure addiction up to heroin and opioid addicting.
“It can turn out [drugs] don’t work. That’s the risk with biotech. We don’t have that here. We have a downside-protected approach, but we have the full upside of a very broadly diversified company. More than 10 drug programs in development tackling the biggest problem in our time!” – Atai Life Sciences Founder Christian Angermayer
Atai is then encapsulating the study of novel compounds with enabling technologies. Its Introspect tool provides personalized and scalable treatment to those who might not otherwise be able to access high-quality psychological care. EntheogeniX is an AI-enabled computational biophysics platform designed to optimize and accelerate drug discovery.
Watch the full interview to learn how Atai is breaking ground in treating mental health, why the founder got into psychedelics in the first place and Atai’s global operations after a very successful IPO.
Original article: New NASDAQ Psychedelic Stock is an IP Giant | Atai Life Sciences
©2021 Midas Letter. All Rights Reserved.
Source: https://midasletter.com/2021/07/new-nasdaq-psychedelic-stock-is-an-ip-giant-atai-life-sciences/
Anyone can join.
Anyone can contribute.
Anyone can become informed about their world.
"United We Stand" Click Here To Create Your Personal Citizen Journalist Account Today, Be Sure To Invite Your Friends.
Please Help Support BeforeitsNews by trying our Natural Health Products below!
Order by Phone at 888-809-8385 or online at https://mitocopper.com M - F 9am to 5pm EST
Order by Phone at 866-388-7003 or online at https://www.herbanomic.com M - F 9am to 5pm EST
Order by Phone at 866-388-7003 or online at https://www.herbanomics.com M - F 9am to 5pm EST
Humic & Fulvic Trace Minerals Complex - Nature's most important supplement! Vivid Dreams again!
HNEX HydroNano EXtracellular Water - Improve immune system health and reduce inflammation.
Ultimate Clinical Potency Curcumin - Natural pain relief, reduce inflammation and so much more.
MitoCopper - Bioavailable Copper destroys pathogens and gives you more energy. (See Blood Video)
Oxy Powder - Natural Colon Cleanser! Cleans out toxic buildup with oxygen!
Nascent Iodine - Promotes detoxification, mental focus and thyroid health.
Smart Meter Cover - Reduces Smart Meter radiation by 96%! (See Video).